Pricing Log in Create free account

Cumberland Pharmaceuticals Inc. (CPIX) vs Citius Oncology, Inc. (CTOR)

Cumberland Pharmaceuticals Inc. and Citius Oncology, Inc. are both Drug Manufacturers Specialty & Generic companies. Cumberland Pharmaceuticals Inc. is the larger, with a market value of $75.1M against $46.5M — 1.6× the size. Citius Oncology, Inc. has the higher net margin (0.00% vs −34.9%) and the lower return on invested capital (−67.2% vs −34.2%). Across the 13 metrics below, Cumberland Pharmaceuticals Inc. leads on 10 and Citius Oncology, Inc. on 3.

Valuation

Metric CPIX CTOR Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 2.41 n/m 2.08
P/B 4.41 1.36 1.79
Price to free cash flow 131.12 n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 2.62 n/m 2.87
Earnings yield (14.48%) (92.16%) (15.94%)
Free cash flow yield 0.76% (58.41%) 0.00%

Profitability

Metric CPIX CTOR Drug Manufacturers Specialty & Generic median
Gross margin 110.49% — 53.51%
Operating margin (23.20%) 0.00% 0.00%
Net margin (34.92%) 0.00% (2.45%)
Free cash flow margin 1.84% 0.00% 0.00%
Return on equity (48.76%) (126.58%) (0.80%)
Return on assets (16.70%) (45.20%) (1.67%)
Return on invested capital (34.23%) (67.15%) 0.00%

Growth

Metric CPIX CTOR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (25.68%) — 5.22%
EPS growth (last fiscal year) 58.70% (9.68%) 42.91%
Revenue growth, 5-year CAGR 3.52% — 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CPIX CTOR Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.50 0.04
Current ratio 0.96 0.73 2.41
Net debt to EBITDA (4.58) (0.40) 1.01

Dividend

Metric CPIX CTOR Drug Manufacturers Specialty & Generic median
Dividend yield 0.00% — 1.45%
Payout ratio — — 0.27

Size

Metric CPIX CTOR Drug Manufacturers Specialty & Generic median
Market cap 75.06m 46.50m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack